Cocrystal Pharma, Inc. Common Stock
Symbol: COCP (NASDAQ)
0.00
▼ (-100.00%) -1.440
Company Description:
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).
Key Stats
- Today's Open: $0
- Today's High: $0
- Today's Low: $0
- Today's Volume: 0
- Yesterday Close: $1.44
- Yesterday High: $1.47
- Yesterday Low: $1.43
- Yesterday Volume: 21.92K
- Last Min Volume: 0
- Last Min High: $0
- Last Min Low: $0
- Last Min VWAP: $0
Company Profile
- Name: Cocrystal Pharma, Inc. Common Stock
- Website: https://www.cocrystalpharma.com
- Listed Date: 2008-04-01
- Location: BOTHELL, WA
- Market Status: Active
- CIK Number: 0001412486
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $14.98M
- Round Lot: 100
- Outstanding Shares: 10.26M
- Asset Type: CS
RECENT FILINGS FOR COCP
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-14 | 10-Q | View |
| 2025-08-14 | 8-K | View |
| 2025-08-05 | 8-K | View |
| 2025-07-10 | 8-K | View |
| 2025-07-01 | 8-K | View |
| 2025-06-18 | 8-K | View |
| 2025-06-05 | 8-K | View |
| 2025-05-29 | 8-K | View |
| 2025-05-15 | 8-K | View |
| 2025-05-15 | 10-Q | View |
| 2025-05-05 | DEFA14A | View |
| 2025-05-05 | DEF 14A | View |
| 2025-04-25 | PRE 14A | View |
| 2025-04-24 | 8-K | View |
| 2025-04-23 | 8-K | View |
| 2025-04-08 | 8-K | View |
| 2025-04-01 | 8-K | View |
| 2025-03-31 | 10-K | View |
| 2025-03-31 | 8-K | View |
| 2025-01-13 | 8-K | View |
Latest News on COCP